ASA Connect

 View Only

Announcing the 2023 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AI and Causality

  • 1.  Announcing the 2023 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AI and Causality

    Posted 02-17-2023 17:57

    We would like to invite you to register for the 2023 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine, which is jointly sponsored by Pfizer Inc., the Roux Institute at Northeastern University and the American Statistical Association.

    As in the past, the symposium is intended to serve as a platform for distinguished statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; to foster collaboration among industry, academia, regulatory agencies, and professional associations; and to propose recommendations with policy implications for proper implementation of AI in promoting public health.

    The theme of this year's conference is AI and Causality, and features Nobel laureate Guido Imbens of Stanford University as the keynote speaker.

    The one-day symposium is scheduled for June 5, 2023, at the Portland Ocean Gateway, Portland, Maine. 

    Details of the symposium, which may be attended in-person or virtually, can be found at:
     https://roux.northeastern.edu/aipm/



    ------------------------------
    Demissie Alemayehu, Pizer Inc, and David Madigan, Northeastern University
    Co-Chairs

    ------------------------------